PPARG and chronic myelogenous leukemia, BCR-ABL1 positive: It was shown that pioglitazone, a synthetic PPARγ ligand used in the treatment of diabetes, can stimulate proliferation of quiescent LSCs isolated from patients in chronic phase (CP) of CML.